Abstract
Neuroleptic-induced akathisia (NIA) is a relatively common side effect of neuroleptics, in which patients complain of a subjective sense of restlessness usually referable to the legs and have characteristic motor movements. This paper will review: 1) history of spontaneously occurring syndromes of pathologic restlessness and NIA, 2) the clinical significance of NIA, 3) issues concerning the diagnosis and quantification of NIA, 4) treatments of NIA and 5) possible future directions for research in this area. Special attention will be paid to newer treatments for this syndrome, specifically beta-blockers.
Similar content being viewed by others
References
Adler L, Angrist B, Peselow E, Corwin J, Rotrosen J (1985) Efficacy of propranolol in neuroleptic-induced akathesia. J Clin Psychopharmacol 5:164–166
Adler L, Angrist B, Peselow E, Corwin J, Maslansky R, Rotrosen J (1986) A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisia. Br J Psychiatry 149:42–45
Adler L, Angrist B, Peselow E, Reitano J, Rotrosen J (1987a) Clonidine in neuroleptic-induced akathisia. Am J Psychiatry 144:235–236
Adler LA, Reiter S, Corwin J, Hemdal P, Angrist B, Rotrosen J (1987b) Differential effects of benztropine and propranolol in akathisia. Psychopharmacol Bull 23:519–521
Adler LA, Reiter S, Angrist B, Rotrosen J (1987c) Pindolol and propranolol in neuroleptic-induced akathisia. Am J Psychiatry 144:1241–1242
Ayd FJ (1960) Drug-induced extrapyramidal reactions: their clinical manifestations and treatment with akineton. Psychosomatics 1:143–150
Ayd FJ (1961) A survery of drug-induced extrapyramidal reactions. JAMA 175:1054–1060
Barnes TRE, Braude WM (1985) Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 42:874–878
Barnes TRE, Braude WM (1986) Toward a more reliable diagnosis of akathisia (in reply). Arch Gen Psychiatry 43:1016
Bartels M, Heide K, Mann K, Schied (1987) Treatment of akathisia with lorazepam: an open trial. Pharnacopsychiatry 20:51–53
Beard GM (1880) A practical treatise on nervous exhaustion, 2nd edn. Wood, New York, pp 41–42
Bing R (1919) A textbook of nervous diseases. (Allen CL trans) Rebman Company. New York, p 412
Bing R (1923) Über einige bemerkenswerte Begleiterscheinungen der exrapyramidalen Rigidität (Akathesie — Mikrographie —Kinesia paradoxica). Schweiz Med Wochenschr 53:167–171
Blom S, Ekbom KA (1961) Comparison between akathisia developing on treatment with phenothiazine derivative and the restless leg syndrome. Acta Med Scand 170:689–694
Braude WM, Barnes TRE (1983) Late onset akathisia — an indicant of covert dyskinesia: two case reports. Am J Psychiatry 140:611–612
Braude WM, Barnes TRE, Gore SM (1983) Clinical characteristics of akathisia. Br J Psychiatry 143:134–150
Brown KW, Glen SE, White T (1987) Low serum iron status and akathisia. Lancet I:1234–1236
Charney DS, Sternber DE, Kleber HD, Henninger GR, Redmond DE (1981) The clinical use of clonidine in abrupt withdrawal from methadone. Arch Gen Psychiatry 38:1273–1277
Chouinard G, Annable L, Ross-Chouinard A, Nestoros JN (1979) Factors related to tardive dyskinesia. Am J Psychiatry 136:79–83
Chouinard G, Ross-Chouinard A, Annable L, Jones BD (1980) Extrapyramidal rating scale. Can J Neurol Sci 7:233
Crane GE (1972) Pseudoparkinsonism and tardive dyskinesia. Arch Neurol 27:426–430
Cruickshank DM (1980) The clinical importance of cardioselectivity and lipophilicity in beta blockers. Am Heart J 100:160–178
Delay J, Deniker P, Green A, Mordret M (1957) Le syndrome exitomoteur provoque pat les medicaments neuroleptiques. Press Med 65:1771–1774
Derom E, Elinck W, Buylaert W, Van der Straeten M (1984) Which beta-blocker for the restless leg? Lancet I:857
DiMascio A, Bernardo DL, Greenblatt D, Marder JE (1976) A controlled trial of amantadine in drug-induced extrapyramidal disorders. Arch Gen Psychiatry 33:559–602
Donlon P (1973) The therapeutic use of diazepam for akathisia. Psychosomatics 14:222–225
Drachman DA (1977) Central cholinergic system and memory. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 28–233
Drake RE, Ehrlich J (1985) Suicide attempts associated with akathisia. Am J Psychiatry 142:499–501
Dupuis B, Catteau J, Dumon J-P, Libert C, Petit H (1987) Comparison of propranolol, sotalol, and betaxolol in the treatment of neuroleptic-induced akathisia. Am J Psychiatry 144:802–805
Ekbom KA (1944) Astehnia Crurum Paraesthetica (“Irritable legs”). Acta Med Scand 118:197–209
Ekbom KA (1960) Restless leg syndrome. Neurology 10:868–873
Freyhan FA (1957) Psychomotility and parkinsonism in treatment with neuroleptic drugs. Arch Neurol Psychiatry 78:465–472
Friis T, Christensen TR, Gerlach J (1982) Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia: a double-blind cross-over study with placebo. Acta Psychiatr Scand 67:178–187
Frishman WM, Sonnenblick EH (1986) Beta-adrenergic blocking drugs. In: Hurst JW, Logue RB, Rackley CE, Sonnenblick EH, Wallace AG, Wenger NK (eds) The heart, 6th edn, McGrawhill, New York, pp 1606–1621
Gagrat D, Hamilton J, Belmatier R (1978) Intravenous diazepam in the treatment of neuroleptic-induced dystonia or akathisia. Am J Psychiatry 135:1232–1233
Gold MS, Redmond DE, Kleiber HD (1978) Clonidine blocks the acute opiate withdrawal syndrome. Lancet II:403–405
Greendyke RM, Kanter DR (1987) Plasma propranolol levels and their effect on thioridazine and haloperidol concentrations. J Clin Psychopharmacology 7:178–182
Guidicelli JF, Richer C, Ganansia J, Warrington S, Abriol C, Rulliere R (1983) Betaxolol: β-Adrenoceptor blocking effects and phamacolinetics in man. In: Morselli PL, Kilborn JR, Cavero I, Harrison DC, Langer SZ (eds) Betaxolol and other β-adrenoceptor antagonists. Raven Press, New York, pp 89–99
Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50–55
Haskovec L (1903) Nouvelles remarques sur l'akathisie. Nouv Iconograph Salpetrière 16:287–296
Jeste DV, Wyatt RJ (1982) Understanding and treating tardive dyskinesia. The Guilford Press, New York London, p 64
Kane JM, Woerner M, Weinhold P, Wegner J, Kinon B (1982) A prospecitive study of tardive dyskinesia development: preliminary results. J Clin Psychopharmacology 2:345–349
Keckich WA (1978) Violence as a manifestation of akathisia. JAMA 240:2185
Kendler (1976) A medical student's experience with akathisia. Am J Psychiatry 133:454–455
Koch-Weser J (1979) Metroprolol. New Engl J Med 301:698–703
Kruse W (1960) Treatment of drug-induced extrapyramidal symptoms. Dis Nerv Syst 21:79–81
Kulik AV, Wilbur R (1983) Case report of propranolol (Inderal) pharmacotherapy for neuroleptic-induced akathisia and tremor. Prog Neuropsychopharmacol Biol Psychiatry 7:223–225
Kutcher SP, Mackenzie S, Galarraga, Szalai J (1987) Clonazepam treatment of adolescents with neuroleptic-induced akathisia. Am J Psychiatry 144:823–824
Langer SZ (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 60:481–497
Lipinski JF, Zubenko GS, Barriera P, Cohem BM (1983) Propranolol in the treatment of neuroleptic-induced akathisia. Lancet II:685–686
Lipinski JF, Zubenko GS, Cohen BM, Barriera PJ (1984) Propranolol in the treatment of neuroleptic-induced akathisia. Am J Psychiatry 141:412–415
Marsden CD, Jenner P (1980) The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med 10:55–72
Merrick EM, Schmitt PP (1973) A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel). Curr Ther Res 15:552–558
Munetz MR (1986) Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 43:1015
Munetz MR, Cornes CL (1982) Distinguishing akathisia and tardive dyskinesia: A review of the literature. J Clin Psychopharmacol 3:343–350
Neu C, DiMascio A, Demirgian E (1972) Antiparkinsonian medication in the treatment of extrapyramidal side-effects: single or multiple doses? Curr Ther Res 4:246–251
Patterson JF (1986) Pseudoakathisia associated with atenolol. J Clin Psychopharmacol 6:390
Ratey JJ, Sorgi P, Polakoff S (1985) Nadolol as a treatment for akathisia. Am J Psychiatry 142:640–642
Reiter S, Adler L, Angrist B, Corwin J, Rotrosen J (1987a) Atenolol and propranolol in neuroleptic-induced akathisia. J Clin Psychopharmacol 7:279–280
Reiter S, Adler L, Erle S, Duncan E (1987b) Neuroleptic-induced akathisia treated with pindolol. Am J Psychiatry 144:383–384
Roehrich H, Gold MS (1987) Propranolol as adjunct to clonidine in opiate detoxification. Am J Psychiatry 144:1099–1100
Shaw ED, Mann JJ, Widen P, Sinscheimer LM, Brunn RD (1986) A case of suicidal and homicidal ideation and akathisia in a double-blind neuroleptic crossover study. J Clin Psychopharmacol 6:196–197
Shear K, Frances A, Weiden P (1983) Suicide associated with akathisia and depot fluphenazine treatment. J Clin Psychopharmacol 3:235–236
Silver JM, Yudofsky SC, Kogan M, Katz BI (1986) Elevation of thioridazine plasma levels by propranolol. Am J Psychiatry 143:1290–1292
Simpson GM (1977) Neurotoxicity of major tranquilizers. In: Roizin L, Shiroki H, Grcevic N (eds) Neurotoxicology. Raven Press. New York, p 3
Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side-effects. Acta Psychiatry Scand [Suppl] 212:11–19
Stahl SM (1985) Akathisia and tardive dyskinesia: changing concepts. Arch Gen Psychiatry 42:915–917
Stenson RL, Donlon PT, Meyer JE (1976) Comparison of benztropine mesylate and amantdine HCl in neuroleptic-induced extrapyramidal symptoms. Compr Psychiatry 17:763–768
Strang RR (1967) The symptom of restless legs. Med J Austr 24:1211–1213
Trzepacz P, Violette EJ, Sateia MJ (1984) Opiates and restless legs. Am J Psychiatry 141:993–995
Van Putten T (1974) Why do schizophrenic patients refuse to take their drugs. Arch Gen Psychiatry 31:67–72
Van Putten T (1975) The many faces of akathisia. Compr Psychiatry 16:43–47
Van Putten T, Marder SR (1987) Behavioral toxicity of antipsychotic drugs. J Clin Psychiatry [Suppl 9] 48:13–19
Van Putten T, Mutalipassi LR, Malkin SR (1974) Phenothiazine induced decompensation. Arch Gen Psychiatry 30:102–105
Van Putten T, May PRA, Marder SR (1984) Akathisia with haloperidol and thiothixene. Arch Gen Psychiatry 41:1036–1039
Washton AM, Resnick RB (1981) Clonidine in opiate withdrawal: review and appraisal of clinical findings. Pharmacotherapy 1:140–146
Weiden P (1985) Akathisia from prochlorperazine. JAMA 253:635
Willis T (1985) The London practice of physic, 1st edn. Bassett and Crooke. London, p 404
Wilson SA, Kinnier (1940) In: Bruce AN (ed) Neurology, vols 1 and 2. A William Wood book. Williams and Wilkins. Baltimore, p 118, (vol 1) and p 793 (vol 2)
Wilcox JA, Tsuang J (1987) Amantadine and psychosis. Presented at the 42nd Annual Meeting of the Society of Biological Psychiatry, Chicago, Illinois, May 6–10
Zubenko GS, Cohen BM, Lipinski JF, Jonas JM (1984a) Use of clonidine in the treatment of akathisia. Psychiatr Res 13:253–259
Zubenko GS, Garreira P, Lipinski JF (1984b) Development of tolerance to the therapeutic effect of amantadine on akathisia. J Clin Psychopharmacol 4:218–219
Zubenko GS, Lipinski JF, Cohen BM, Barriera PJ (1984c) Comparison of metoprolol and propranolol in the treatment of akathisia. Psychiatr Res 11:143–148
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adler, L.A., Angrist, B., Reiter, S. et al. Neuroleptic-induced akathisia: a review. Psychopharmacology 97, 1–11 (1989). https://doi.org/10.1007/BF00443404
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00443404